336194-97-9

Basic information

• Product Name: N-cyclopropylmethyl-N'-(2,6-dichloro-4-iodo-phenyl)-2-methyl-N-propyl-pyrimidine-4,6-diamine
• CAS NO: 336194-97-9
• Molecular Weight: 491.202
• Mol File: 336194-97-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-cyclopropylmethyl-N'-(2,6-dichloro-4-iodo-phenyl)-2-methyl-N-propyl-pyrimidine-4,6-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-cyclopropylmethyl-N'-(2,6-dichloro-4-iodo-phenyl)-2-methyl-N-propyl-pyrimidine-4,6-diamine(336194-97-9)
• EPA Substance Registry System: N-cyclopropylmethyl-N'-(2,6-dichloro-4-iodo-phenyl)-2-methyl-N-propyl-pyrimidine-4,6-diamine(336194-97-9)

Safety Data

• Hazardous Substances Data: 336194-97-9(Hazardous Substances Data)

Upstream product

• 697-89-2 2,6-dichloro-4-iodoaniline 
• 1780-26-3 2,4-dichloro-2-methylpyrimidine 
• 26389-60-6 N-(n-propyl)-N-(cyclopropanemethyl)amine 
• 336194-95-7 (6-chloro-2-methyl-pyrimidin-4-yl)-(2,6-dichloro-4-iodo-phenyl)-amine 

Relevant articles and documents

The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1

A high-affinity radioligand for CRHR1 has been prepared that can serve as a template for the development of SPECT imaging agents. The 5-chloro-N-cyclopropylmethyl-N-(2,6-dichloro-4-iodophenyl)-2-methyl-N-propylp yrimidine-4,6-diamine (6b, Ki = 14 nM), and the corresponding 4-bromophenyl analogue (6a, Ki = 21 nM), were synthesized in four steps from compound 3.